子痫前期分娩住院期间抗高血压药物的使用
基于Perspective数据库的回顾性队列研究,纳入2006年至2015年第一季度子痫前期分娩住院患者239,454例,评估抗高血压药物使用趋势及孕产妇卒中风险。结果显示任何抗高血压药物使用比例从2006年37.8%升至2015年49.4%,多种药物使用增加,重度子痫前期卒中风险从2006-2008年13.5/万降至2012-2014年6.0/万(P=.02)。
要点
- 子痫前期患者任何抗高血压药物使用比例从2006年37.8%升至2015年49.4%。
- 口服拉贝洛尔从20.3%升至31.4%,静脉拉贝洛尔从13.3%升至21.4%。
- 重度子痫前期卒中风险从13.5/万分娩降至6.0/万分娩(P=.02)。
核心结论
- 子痫前期患者使用多种抗高血压药物的比例在研究期间增加,医院间使用率差异显著,该趋势与孕产妇卒中风险降低相关。
研究设计与样本
- 利用Perspective数据库进行的回顾性队列研究,评估2006年至2015年第一季度子痫前期分娩住院期间抗高血压药物使用情况。
- 共纳入239,454例子痫前期患者,其中轻度126,595例、叠加子痫前期31,628例、重度81,231例。
- 评估药物包括硝苯地平、肼屈嗪以及口服和静脉拉贝洛尔,并建立校正人口学和医院因素的模型。
主要发现
- 总体105,409名女性接受了抗高血压药物。
- 2006年至2014年,所有子痫前期患者中口服拉贝洛尔使用从20.3%升至31.4%,静脉拉贝洛尔从13.3%升至21.4%,肼屈嗪从12.8%升至16.9%,硝苯地平从15.0%升至18.2%,使用一种以上药物从16.5%升至25.8%。
- 子痫前期患者接受任何抗高血压药物的比例从2006年37.8%升至2015年49.4%。
- 校正模型显示时间趋势仍具统计学显著性。
- 重度子痫前期抗高血压药物使用率在医院间差异显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate temporal trends in use of antihypertensive medications during delivery hospitalizations complicated by preeclampsia and risk of maternal stroke over the same time period. METHODS: The Perspective database was used to perform a retrospective cohort study evaluating antihypertensive drugs dispensed during delivery hospitalizations complicated by preeclampsia from 2006 to the first quarter of 2015. Medications evaluated included nifedipine, hydralazine, and oral and intravenous labetalol. Adjusted models for receipt of antihypertensive agents accounting for demographic and hospital factors were created. Hospital-level rates of antihypertensive administration for women with severe preeclampsia were analyzed. Risk of stroke during delivery hospitalization was evaluated. RESULTS: A total of 239,454 patients with preeclampsia were included in the analysis including 126,595 women with mild, 31,628 with superimposed, and 81,231 with severe preeclampsia. Overall, 105,409 women received a hypertensive agent. From 2006 to 2014, for all patients with preeclampsia, receipt of oral labetalol increased from 20.3% to 31.4%, intravenous labetalol from 13.3% to 21.4%, hydralazine from 12.8% to 16.9%, nifedipine from 15.0% to 18.2%, and more than one medication from 16.5% to 25.8%. The proportion of patients with preeclampsia receiving any antihypertensive medication rose from 37.8% in 2006 to 49.4% in 2015. In adjusted models, temporal trends retained significance. Rates of antihypertensive administration for severe preeclampsia varied significantly by hospital. For severe preeclampsia, the risk for stroke decreased from 13.5 per 10,000 deliveries in 2006-2008 (n=27) to 9.7 in 2009-2011 (n=25) to 6.0 in 2012-2014 (n=20) (P=.02). CONCLUSION: Use of multiple antihypertensive agents to treat preeclamptic women increased over the study period for women with mild, superimposed, and severe preeclampsia. There was substantial hospital variation in use of antihypertensive agents. This trend was associated with decreased risk of maternal stroke.
引用
- Cleary KL, Siddiq Z, Ananth CV, et al. Use of Antihypertensive Medications During Delivery Hospitalizations Complicated by Preeclampsia. Obstet Gynecol. 2018. PMID: 29420396. doi:10.1097/AOG.0000000000002479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。